KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $1.2 billion.

  • Xylem's Accumulated Expenses rose 606.33% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 606.33%. This contributed to the annual value of $1.3 billion for FY2024, which is 409.5% up from last year.
  • As of Q3 2025, Xylem's Accumulated Expenses stood at $1.2 billion, which was up 606.33% from $1.2 billion recorded in Q2 2025.
  • Xylem's Accumulated Expenses' 5-year high stood at $1.3 billion during Q4 2024, with a 5-year trough of $713.0 million in Q1 2022.
  • Moreover, its 5-year median value for Accumulated Expenses was $1.1 billion (2023), whereas its average is $972.4 million.
  • In the last 5 years, Xylem's Accumulated Expenses surged by 4083.04% in 2023 and then crashed by 474.14% in 2024.
  • Quarter analysis of 5 years shows Xylem's Accumulated Expenses stood at $752.0 million in 2021, then rose by 15.29% to $867.0 million in 2022, then skyrocketed by 40.83% to $1.2 billion in 2023, then grew by 4.1% to $1.3 billion in 2024, then dropped by 7.79% to $1.2 billion in 2025.
  • Its Accumulated Expenses stands at $1.2 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.2 billion for Q1 2025.